Papers
2
Total Citations
75
H-Index
2
About
R. Valdagni is a leading figure in prostate cancer research, with a career dedicated to improving patient outcomes through multidisciplinary care and advanced radiotherapy techniques. His work centers on the integration of clinical decision-making and technological innovation, particularly in the management of prostate cancer. A landmark contribution is his 2012 study on the 6-year attendance of a multidisciplinary prostate cancer clinic in Italy, which demonstrated significant changes in patient management and has been cited 54 times, underscoring its impact on collaborative cancer care. Valdagni also advanced stereotactic body radiation therapy (SBRT) with his 2013 work on standardizing dose constraints for CyberKnife treatments, addressing the challenge of balancing tumor control with organ-at-risk protection; this study, with 21 citations, highlights his role in enhancing plan quality and consistency. Through these efforts, Valdagni has shaped evidence-based protocols that bridge clinical practice and technical precision, making him a pivotal contributor to modern prostate oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2